Accessibility Menu
Streamex Stock Quote

Streamex (NASDAQ: BSGM)

$4.84
(-7.1%)
-0.37
Price as of October 22, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$4.84
Daily Change
(-7.1%) $0.37
Day's Range
$4.66 - $5.2
Previous Close
$4.84
Open
$5.14
Beta
1.01
Volume
1,254,256
Average Volume
1,150,656
Market Cap
183.8M
Market Cap / Employee
$5.21M
52wk Range
$0.4 - $14.11
Revenue
-
Gross Margin
-47.92%
Dividend Yield
N/A
EPS
-$1.06
CAPs Rating
-
Industry
Healthcare Equipment and Supplies

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Streamex Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
BSGM+622.39%-90.36%-37.36%-94%
S&P+14.5%+93.32%+14.09%+236%

Streamex Company Info

BioSig Technologies, Inc. is a medical technology company, which engages in the development of a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of electrocardiographic and intra-cardiac signals. Its product PURE EP System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing of electrocardiographic and intra-cardiac signals for patients undergoing electrophysiology procedures. The company was founded by Kenneth L. Londoner on February 24, 2009 and is headquartered in Westport. CT.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$0.00M-100.0%
Gross Profit-$0.55M-1438.9%
Gross Margin-130.77%544.2%
Market Cap$194.88M3841.7%
Market Cap / Employee$38.98M0.0%
Employees525.0%
Net Income-$20.37M-420.8%
EBITDA-$19.81M-277.9%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$2.82M34.0%
Accounts Receivable$0.00M-100.0%
Inventory00.0%

Liabilities

Q2 2025YOY Change
Long Term Debt$0.00M-100.0%
Short Term Debt$0.02M-94.4%

Ratios

Q2 2025YOY Change
Return On Assets-46.44%454.7%
Return On Invested Capital-364.47%201.9%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$1.28M13.7%
Operating Free Cash Flow-$1.28M13.7%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book-850.00-61.14-24.6766.46-7447.10%
Price to Sales141.24642.16480.6815217.4213360.82%
Price to Tangible Book Value-18.03-36.46-14.7173.99-8818.88%
Enterprise Value to EBITDA-1.77-22.35-3.03-9.851730.24%
Return on Equity-8041.7%-
Total Debt$0.15M$0.10M$0.06M$0.02M-94.68%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.